Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 10, 1996, Pages 954-958

  Hatlebakk, J G ^a   Berstad, A ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

gastro oesophageal reflux; ranitidine; reflux oesophagitis; tolerance

Indexed keywords

RANITIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERANCE; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REGRESSION ANALYSIS; STOMACH PH;

EID: 0029816232     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609003113     Document Type: Article

References (19)

1. Jones RH, Lydeard SE, Hobbs FDR, Kenkre JE, Williams EI, Jones SJ, et al. Dyspepsia in England and Scotland. Gut 1990;31:401-5.
2. Nebel OT, Formes MF, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Dig Dis Sci 1976;21:953-6.
3. Howard PJ, Heading RC. Epidemiology of gastro-esophageal reflux disease. World J Surg 1992;16:288-93.
4. Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987;22:714-8.
5. Berstad A, Weberg R, Frøyshov Larsen I, Hoel B, Hauer-Jensen M. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy. Scand J Gastroenterol 1986;21:55-8.
6. Graham DY, Lacey Smith J, Patterson DJ. Why do apparently healthy people use antacid tablets? Am J Gastroenterol 1983;78: 257-60.
7. Jansen JBMJ, Baak LC, Lamers CBHW. Effect of increasing doses of ranitidine on exposure of the esophagus to gastric acid in patients with reflux oesophagitis. Scand J Gastroenterol 1988; 23 Suppl 154:2-5.
8. Aadland E, Berstad A. Effect of cimetidine on pentagastrin-stimulated gastric acid and pepsin secretion before and after 6 weeks of cimetidine treatment. Scand J Gastroenterol 1978;13: 193-7.
9. Prichard PJ, Jones DB, Yeomans ND, Mihaly GW, Smallwood RA, Louis WJ. The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy. Br J Clin Pharmacol 1986;22:663-8.
10. Nwokolo CU, Smith JTL, Gavey C, Sawyerr A, Pounder RE. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 1990;4 Suppl 1:29-46.
11. 2-blockade: placebo-controlled studies of 24-hour acidity and gastrin. Aliment Pharmacol Ther 1990;4 Suppl 1:47-63.
12. 2-receptor antagonists. Aliment Pharmacol Ther 1990;4 Suppl 1:15-28.
13. Hurlimann S, Abbühl B, Inauen W, Halter F. Comparison of acid inhibition ot either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 1994;8:193-201.
14. Bell NJV, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastrooesophageal reflux disease. Digestion 1992;51 Suppl 1:59-67.
15. Hatlebakk JG, Berstad A, Carling L, Svedberg L-E, Unge P, Ekström P, et al. Lanzoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Scand J Gastroenterol 1993;28: 224-8.
16. Berstad K, Wilhelmsen I, Berstad A. Biometric evaluation of gastric urease activity in man. Scand J Gastroenterol 1992;28: 224-8.
17. 2-rcceptor antagonists: intragastric acidity in patients with duodenal ulcer. Dig Dis Sci 1991;36:1685-90.
18. Hatlebakk JG, Berstad A. Comparison between the endoscopic picture and parameters of gastro-esophageal reflux in reflux esophagitis. Gastroenterology 1991;100:A80.
19. Lacey Smith J, Opekun AR, Larkai E, Graham DY. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989;96:683-9.